Rachel Lanier is Managing Attorney of the Los Angeles Office and member of the Lanier Law Firm Trial Team. She practices in the areas of personal injury, toxic torts, pharmaceutical litigation, mass torts, and product liability.
When she is not passionately advocating for her clients, Mrs. Lanier enjoys spending time with her family and exploring the Los Angeles restaurant scene.
Representative Cases
- Co-led the trial work-up in Ingham v. Johnson & Johnson et al in Missouri State Court, where LLF represented 22 women who suffered from and/or died from ovarian cancer caused by talcum powder exposure and played a significant role in obtaining the unanimous $4.6 billion verdict on behalf of the plaintiffs. Mrs. Lanier was also extensively involved in the appellate work that led to the Supreme Court of the United States rejecting J&J’s appeal, effectively ending the case and leaving in place a Missouri appeals-court ruling against the company.
- On the trial team for the first bellwether trial in the National Prescription Opiates Litigation MDL 2804 that won a verdict against retail pharmacies operated by Walmart, CVS and Walgreens finding that they failed to follow guidelines that would have curtailed the distribution of highly addictive opioid painkillers.
- Part of the trial team for two trials in the DePuy Pinnacle Hip Implant MDL 2244 in the Northern District of Texas, which resulted in verdicts of more than $1 billion.
- Did considerable work on the Epipen Litigation MD 2785 before Judge Daniel Crabtree, a case that was ultimately resolved out of court.
- Currently represents hundreds of coal miners who are pursuing black lung cases against mask manufacturer 3M throughout Kentucky and West Virginia.